mild pleurisy NSAIDs Addition of antimalarials for long-term management Most moderate SLE manifestations Oral glucocorticoids 0.25–0.5 mg/kg prednisone (or equivalent) Addition of antimalarials ...

Management Intravenous methylprednisolone ... that progressed to coma over a few days. Her medical history was significant for a diagnosis of SLE 3 years earlier, which was made on the basis ...

In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for developing multiple cutaneous lupus erythematosus disease (CLE, lupus skin disease) subtype diagnoses ...

Patients with SLE vs individuals without autoimmune disease demonstrated higher rates of peripartum complications.

Bullous systemic lupus erythematosus (BSLE ... can also advise them on possible complications and ways to manage them. Medical News Today has strict sourcing guidelines and relies on peer-reviewed ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

He holds cross-appointments with the Institute of Health Policy Management and Evaluation (IHPME) and Institute of Medical Sciences graduate ... His research is focused on patients with systemic lupus ...

Henry W. Chen, MD, from the University of Texas Southwestern Medical Center in Dallas, and colleagues examined the incidence and prevalence of ASCVD among individuals with CLE, SLE, and psoriasis ...

Future studies should explore the relationship between MHT and clinical phenotypes in SLE and SSc. The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly ...

Agents such as azathioprine, methotrexate and cyclosporine A have been used for several decades in the management of SLE, but the evidence for their efficacy in nonrenal lupus has remained limited.

ADI-001 is an allogeneic gamma delta CAR T-cell therapy that targets the B-cell antigen CD20. The Food and Drug Administration (FDA) has granted Fast Track designation to ADI-001 for the treatment ...